Skip to content
approvedImmune & Inflammation

Nisin

Also known as: Nisin A, Nisin Z, Nisaplin, Lantibiotic Nisin, E234

Nisin is a 34-amino acid lantibiotic (lanthionine-containing antibiotic) naturally produced by the bacterium Lactococcus lactis during fermentation. It is the only antimicrobial peptide with FDA GRAS (Generally Recognized As Safe) status for use as a food preservative. Used commercially since the 1950s, nisin is effective against gram-positive pathogens including Listeria, Staphylococcus, and Clostridium species, and is now being investigated for medical applications including wound care and anti-biofilm therapies.

3 cited references·6 researched benefits

Quick Answer

Nisin is a 34-amino acid lantibiotic produced by Lactococcus lactis, FDA-approved as a food preservative (GRAS status) since 1988. It kills gram-positive bacteria including Listeria and MRSA by binding to lipid II (a cell wall precursor) and forming pores in bacterial membranes. With over 50 years of safe use in food, nisin is now being investigated for medical applications including wound healing, anti-biofilm treatments, and as an alternative to conventional antibiotics.

Key Facts

Mechanism
Nisin kills bacteria through a dual mechanism targeting lipid II, an essential precursor molecule in bacterial cell wall synthesis. First, it binds to the pyrophosphate moiety of lipid II with high affinity, blocking peptidoglycan synthesis. Second, using lipid II as a docking molecule, nisin inserts into the bacterial membrane and oligomerizes to form stable pores approximately 2 nm in diameter, causing rapid membrane depolarization, loss of amino acids and ATP, and cell death. This dual mechanism makes resistance development extremely rare, as bacteria would need to simultaneously alter a fundamental cell wall component and membrane composition.
Research Status
approved
Half-Life
~30 minutes to several hours (pH and protease dependent)
Molecular Formula
C₁₄₃H₂₂₈N₄₂O₃₇S₇
Primary Use
Immune & Inflammation
Table of Contents

Benefits

  • Potent bactericidal activity against gram-positive pathogens including MRSA and Listeriastrong
  • Over 50 years of documented safe use in food preservation worldwidestrong
  • Extremely low resistance development due to dual mechanism targeting lipid IIstrong
  • Anti-biofilm activity disrupts established gram-positive bacterial biofilmsmoderate
  • Potential wound care applications as a topical antimicrobial agentpreliminary
  • Synergistic effects when combined with conventional antibiotics against resistant bacteriamoderate

Dosage Protocols

RouteDosage RangeFrequencyNotes
Food preservative (oral)2.5–25 mg/kg of food productAs formulatedFDA GRAS status; used commercially in dairy, meat, and canned products
Topical (investigational)50–500 mcg/mL in wound dressingDaily applicationUnder investigation for wound care and anti-biofilm applications; not yet approved for medical use
Research formulations1–100 mcg/mLVariablePreclinical studies exploring nisin in hydrogels, nanoparticles, and combination antimicrobial formulations

Medical disclaimer

Dosage information is provided for educational reference only. Always follow your prescriber's instructions and consult a qualified healthcare provider before starting any peptide protocol.

Side Effects

  • Generally recognized as safe (GRAS) for oral consumption in food amountscommon
  • Possible local irritation with high-concentration topical applicationrare
  • Allergic reactions in individuals sensitive to dairy-derived productsrare
  • Limited activity against gram-negative bacteria without membrane-permeabilizing agentscommon

Frequently Asked Questions

Is nisin safe to consume?
Yes. Nisin has FDA GRAS (Generally Recognized As Safe) status and has been safely used as a food preservative for over 50 years. It is approved in over 80 countries. Nisin is digested by gastrointestinal enzymes like any other protein, does not accumulate in the body, and does not affect the normal gut microbiome at food-level concentrations. The World Health Organization has established an acceptable daily intake (ADI) of 33,000 IU/kg body weight.
Can nisin replace antibiotics?
Nisin is being investigated as a potential alternative or complement to conventional antibiotics, particularly for topical infections and biofilm-associated conditions. Its dual mechanism of action (lipid II binding plus pore formation) makes bacterial resistance extremely unlikely. However, its limited activity against gram-negative bacteria, susceptibility to protease degradation, and lack of systemic bioavailability mean it is unlikely to replace broad-spectrum antibiotics but may serve as an important topical and adjunct antimicrobial.
Why is nisin only effective against gram-positive bacteria?
Nisin requires direct access to lipid II in the bacterial membrane. Gram-positive bacteria have lipid II accessible at the cell surface beneath a relatively permeable peptidoglycan layer. Gram-negative bacteria have an additional outer membrane that prevents nisin from reaching lipid II. However, when the outer membrane is disrupted by chelating agents (like EDTA) or combined with other antimicrobials, nisin can become effective against gram-negative organisms.
What makes nisin different from other antimicrobial peptides?
Nisin is unique among antimicrobial peptides for several reasons: it is the only AMP with FDA food-grade approval, it has one of the longest track records of commercial use, and its target (lipid II) is different from most other AMPs that target general membrane phospholipids. It also contains unusual amino acids (lanthionine and methyllanthionine) formed by post-translational modification, making it a lantibiotic — a distinct class from defensins or cathelicidins.

References

  1. 1
    Nisin, a peptide lantibiotic — structure, function, and resistance(2006)PubMed ↗
  2. 2
    Nisin and its application as a food preservative — a review(2015)PubMed ↗
  3. 3
    Dual mechanism of action of nisin: binding to lipid II and pore formation(2001)PubMed ↗

Latest Research

Last updated: 2026-02-19